A. Daisy Goodrich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
A. Daisy Goodrich has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Jaehyup Kim
Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
2 shared publications - Peiman Hematti
Division of Hematology/Oncology, BMT & Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
2 shared publications Christine M. Jeanblanc
University of Nevada-Reno, Reno, Nevada
1 shared publication- Deane F. Mosher
Department of Biomolecular Chemistry, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
1 shared publication - Debra D. Bloom
Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison
1 shared publication Esmail D. Zanjani
University of Nevada-Reno, Reno, Nevada
1 shared publication
Latest Publications
- Open Access
- 18 May 2016
- Published by S. Karger AG in Acta Haematologica
- Vol. 136 (2) , 85-97
Fibroblasts and Mesenchymal Stromal/Stem Cells Are Phenotypically Indistinguishable
Background/Aims: Human mesenchymal stromal/stem cells (MSCs), derived from many different tissues, are characterized by a fibroblast-like morphology, the expression of certain cell surface markers and their ability to differentiate into adipocytes, chondrocytes and osteoblasts. A number of studies have shown that MSCs share many characteristics with fibroblasts; however, there is no well-defined set of phenotypic characteristics that could distinguish between these 2 types of cells. Methods: We used 4 well-established human fibroblast strains from 3 different tissue sources and several human MSC strains from 2 different tissue sources to compare the phenotypic and immunological characteristics of these cells. Results: Fibroblast strains had a similar morphology to MSCs, expressed the same cell surface markers as MSCs and could also differentiate into adipocytes, chondrocytes and osteoblasts. Also, similar to MSCs, these fibroblasts were capable of suppressing T cell proliferation and modulating the immunophenotype of macrophages. We also show that MSCs deposit extracellular matrices of collagen type I and fibronectin, and express FSP1 in patterns similar to fibroblasts. Conclusions: Based on currently accepted definitions for cultured human MSCs and fibroblasts, we could not find any immunophenotypic property that could make a characteristic distinction between MSCs and fibroblasts.
- 18 May 2016
- Published by S. Karger AG in Acta Haematologica
- Vol. 136 (2) , 85-97
Open AccessFibroblasts and Mesenchymal Stromal/Stem Cells Are Phenotypically Indistinguishable
Background/Aims: Human mesenchymal stromal/stem cells (MSCs), derived from many different tissues, are characterized by a fibroblast-like morphology, the expression of certain cell surface markers and their ability to differentiate into adipocytes, chondrocytes and osteoblasts. A number of studies have shown that MSCs share many characteristics with fibroblasts; however, there is no well-defined set of phenotypic characteristics that could distinguish between these 2 types of cells. Methods: We used 4 well-established human fibroblast strains from 3 different tissue sources and several human MSC strains from 2 different tissue sources to compare the phenotypic and immunological characteristics of these cells. Results: Fibroblast strains had a similar morphology to MSCs, expressed the same cell surface markers as MSCs and could also differentiate into adipocytes, chondrocytes and osteoblasts. Also, similar to MSCs, these fibroblasts were capable of suppressing T cell proliferation and modulating the immunophenotype of macrophages. We also show that MSCs deposit extracellular matrices of collagen type I and fibronectin, and express FSP1 in patterns similar to fibroblasts. Conclusions: Based on currently accepted definitions for cultured human MSCs and fibroblasts, we could not find any immunophenotypic property that could make a characteristic distinction between MSCs and fibroblasts.
- 1 August 2013
- Published by Elsevier in Experimental Hematology
- Vol. 41 (8) , 749-758.e5
Generation of CD34+ cells from human embryonic stem cells using a clinically applicable methodology and engraftment in the fetal sheep model
- 1 August 2013
- Published by Elsevier in Experimental Hematology
- Vol. 41 (8) , 749-758.e5
Generation of CD34+ cells from human embryonic stem cells using a clinically applicable methodology and engraftment in the fetal sheep model